BIOCON LIMITED. Share Price

NSE

Company Profile


Biocon Limited is a globally recognized, innovation-led organization that is enabling access to high-quality advanced therapies for diseases that are chronic where medical needs are largely unmet and treatment costs are high. The company has developed and commercialized a differentiated portfolio of novel biologics, biosimilars, and complex small molecule APIs in India and several key global markets, as well as, generic formulations in the U.S. and Europe. It is a leading global player for biosimilars and APIs for statins, immunosuppressants, and other specialty molecules, with customers in over 120 countries. It has successfully launched a couple of novel biologics in India- Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis.

Return Calculator

This tools helps you project your potential returns on investments for the given stock, for a specified amount over a pre-defined period of time.

Invested amount

Investment period

1 year
2 year
5 year
=
up down
Returns
CAGR
%